Platelet protein S directly inhibits procoagulant activity on platelets and microparticles

Thrombosis and Haemostasis

Volumn 109, Issue 2, 2013, Pages 229-237

  Stavenuiter, Fabian ^a   Davis, Nicole F ^a   Duan, Erning ^a   Gale, Andrew J ^a   Heeb, Mary J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Activated protein C; Anticoagulant activity; Microparticles; Platelets; Protein S

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; NEUTRALIZING ANTIBODY; PROCOAGULANT; PROTEIN S; PROTEINASE; PROTHROMBIN; THROMBIN;

ANTIBODY AFFINITY; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; THROMBOCYTE; WESTERN BLOTTING;

ANTIBODIES, NEUTRALIZING; BLOOD COAGULATION; BLOOD PLATELETS; BLOTTING, WESTERN; CELL-DERIVED MICROPARTICLES; FACTOR VIIA; FACTOR XA; HUMANS; KINETICS; LIPOPROTEINS; PROTEIN C; PROTEIN S; THROMBIN; THROMBOPLASTIN;

EID: 84874709181     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-08-0622     Document Type: Article

References (32)

1. Tans G, Rosing J, Thomassen MC, Heeb MJ, et al. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991; 77: 2641-2648.
2. Schwarz HP, Heeb MJ, Wencel-Drake JD, et al. Identification and quantitation of protein S in human platelets. Blood 1985; 66: 1452-1455.
3. Schwarz HP, Fischer M, Hopmeier P, et al. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300.
4. Burstyn-Cohen T, Heeb MJ, Lemke G. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J Clin Invest 2009; 119: 2942-2953.
5. Saller F, Brisset AC, Tchaikovski SN, et al. Generation and phenotypic analysis of protein S-deficient mice. Blood 2009; 114: 2307-2314.
6. Heeb MJ, Marzec U, Gruber A, et al. Antithrombotic activity of protein S infused without APC in a baboon thrombosis model. Thromb Haemost 2012; 107: 690-698.
7. Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane-bound FVa by APC. Protein S modulates FXa protection. J Biol Chem 1988; 263: 14884-14890.
8. Harris KW, Esmon CT. Protein S is required for bovine platelets to support APC binding and activity. J Biol Chem 1985; 260: 2007-2010.
9. Lundwall A, Dackowski W, Cohen E, et al. Isolation and sequence of the cDNA for protein S, a regulator of blood coagulation. Proc Natl Acad Sci USA 1986; 83: 6716-6720.
10. Mitchell CA, Salem HH. Cleavage of protein S by a platelet membrane protease. J Clin Invest 1987; 79: 374-379.
11. Long GL, Lu D, Xie RL, et al. Human protein S cleavage and inactivation by coagulation FXa. J Biol Chem 1998; 273: 11521-11526.
12. Heeb MJ, Griffin JH. APC-dependent and-independent anticoagulant activities of protein S have different structural requirements. Blood Cells Mol Dis 2002; 29: 190-199.
13. Brinkman HJ, Mertens K, van Mourik JA. Proteolytic cleavage of protein S during the hemostatic response. J Thromb Haemost 2005; 3: 2712-2720.
14. Heeb MJ, Mosher D, Griffin JH. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Blood 1989; 73: 455-461.
15. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of FV and FVa by APC. J Biol Chem 1994; 269: 31869-31880.
16. O'Brien LM, Mastri M, Fay PJ. Regulation of FVIIIa by APC and protein S: Inactivation of cofactor in the intrinsic FXase. Blood 2000; 95: 1714-1720.
17. Fernandes N, Mosnier LO, Tonnu L, et al. Zn2+-containing protein S inhibits extrinsic FX-activating complex independently of TFPI. J Thromb Haemost 2010; 8: 1976-1985.
18. Heeb MJ, Prashun D, Griffin JH, et al. Plasma protein S contains zinc essential for efficient APC-independent anticoagulant activity and binding to FXa, but not for efficient binding to TFPI. FASEB J 2009; 23: 2244-2253.
19. Chattopadhyay R, Sengupta T, Majumder R. Inhibition of intrinsic Xase by protein S. Arterioscler Thromb Vasc Biol 2012; 32: 2387-2393.
20. Ndonwi M, Broze G, Jr. Protein S enhances the TFPI inhibition of FXa but not its inhibition of FVIIa-tissue factor. J Thromb Haemost 2008; 6: 1044-1046.
21. Hackeng TM, Sere KM, Tans G, et al. Protein S stimulates inhibition of the tissue factor pathway by TFPI. Proc Natl Acad Sci USA 2006; 103: 3106-3111.
22. Heeb MJ, Koenen RR, Fernandez JA, et al. Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals. J Thromb Haemost 2004; 2: 1766-1773.
23. Dahlbäck B, Wiedmer T, Sims PJ. Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles. Biochem 1992; 31: 12769-12777.
24. Heeb MJ, Schuck P, Xu X. Protein S multimers and monomers each have direct anticoagulant activity. J Thromb Haemost 2006; 4: 385-391.
25. Niemetz J, Fallon JT, Harrington E, et al. Rapid generation of thrombin by atheroma and platelets. J Thromb Haemost 2004; 2: 321-326.
26. Heeb MJ, Mesters R, Tans G, et al. Binding of protein S to FVa associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-2877.
27. Ozawa H, Kobayashi I, Marumo M. Is platelet protein S different from plasma protein S in human being?. Japan J Clin Med 1992; 50: 292-296.
28. Monkovic DD, Tracy PB. Functional characterization of platelet-released FV and its activation by FXa and thrombin. J Biol Chem 1990; 265: 17132-17140.
29. Kane WH, Mruk JS, Majerus PW. Activation of coagulation FV by a platelet protease. J Clin Invest 1982; 70: 1092-1100.
30. Rand MD, Kalafatis M, Mann KG. Platelet coagulation FVa: The major secretory platelet phosphoprotein. Blood 1994; 83: 2180-2190.
31. Gould WR, Silveira JR, Tracy PB. Unique in vivo modifications of coagulation FV produce a physically and functionally distinct platelet-derived cofactor: Characterization of purified platelet-derived FV/Va. J Biol Chem 2004; 279: 2383-2393.
32. Stavenuiter F, Heeb MJ. Phosphorylation of protein S by platelet kinases enhances its direct anticoagulant activity. J Thromb Haemost 2011; Vol 9 [abstract].